Medpace Holdings Inc (MEDP):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Medpace Holdings Inc (MEDP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9897
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medpace Holdings Inc (Medpace) is a scientifically-driven full-service clinical contract research organization. It provides Phase I-IV outsourced clinical development services. The company also offers clinical pharmacology; and supporting laboratory services including central laboratory, bioanalytical, core lab, and imaging core labs. Medpace carries out clinical trials across all the therapeutic areas, including cardiology, metabolic disease, endocrinology, central nervous system (CNS), oncology, and antiviral and anti-infective (AVAI). It serves biopharmaceutical, pharmaceutical, biotechnology, and medical device companies in North America, Europe, Africa, Asia Pacific, and Latin America. The company has specialized esoteric testing offices in the US, China, Belgium, and Singapore. Medpace is headquartered in Cincinnati, Ohio, the US.

Medpace Holdings Inc (MEDP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medpace Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medpace Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Cinven Acquires Medpace from CCMP Capital Advisors for USD915 Million 11
Partnerships 13
Actinium Pharma Enters into Agreement with Medpace 13
Medpace Enters into Amendment Agreement with Xenon Pharma 14
Medpace Enters into Agreement with Symplmed Pharmaceuticals 15
Equity Offering 16
Medpace Holdings Prices Public Offering of Shares for USD290 Million 16
Medpace Holdings Prices Public Offering of Shares for USD247.5 Million 18
Medpace Holdings Prices Public Offering of Shares for USD130.5 Million 20
Medpace Raises USD126 Million in Secondary Offering of Shares 21
Medpace Raises USD185.2 Million in IPO 22
Coherus BioSciences Raises USD2.5 Million in Private Placement of Shares 24
Medpace Holdings Inc – Key Competitors 25
Medpace Holdings Inc – Key Employees 26
Medpace Holdings Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Financial Announcements 30
Oct 29, 2018: Medpace Holdings announces third quarter 2018 financial results 30
Jul 30, 2018: Medpace Holdings Reports Second Quarter 2018 Results 32
Apr 30, 2018: Medpace Holdings Announces First Quarter 2018 Financial Results 34
Feb 26, 2018: Medpace Holdings Reports Fourth Quarter 2017 Financial Results 36
Oct 30, 2017: Medpace Holdings Reports Third Quarter 2017 Results 38
Jul 31, 2017: Medpace Holdings Reports Second Quarter 2017 Results 39
May 01, 2017: Medpace Holdings Reports First Quarter 2017 Results 40
Feb 27, 2017: Medpace Holdings Reports Fourth Quarter and Full Year 2016 Results 42
Corporate Communications 44
Mar 15, 2018: Medpace Appoints William John As Senior Medical Director 44
Government and Public Interest 45
May 10, 2018: Medpace’s Flagship Site Programme for High-Achieving Sites Exemplifies Commitment to Accelerating Clinical Research 45
Mar 27, 2018: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors 46
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medpace Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medpace Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Medpace Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cinven Acquires Medpace from CCMP Capital Advisors for USD915 Million 11
Actinium Pharma Enters into Agreement with Medpace 13
Medpace Enters into Amendment Agreement with Xenon Pharma 14
Medpace Enters into Agreement with Symplmed Pharmaceuticals 15
Medpace Holdings Prices Public Offering of Shares for USD290 Million 16
Medpace Holdings Prices Public Offering of Shares for USD247.5 Million 18
Medpace Holdings Prices Public Offering of Shares for USD130.5 Million 20
Medpace Raises USD126 Million in Secondary Offering of Shares 21
Medpace Raises USD185.2 Million in IPO 22
Coherus BioSciences Raises USD2.5 Million in Private Placement of Shares 24
Medpace Holdings Inc, Key Competitors 25
Medpace Holdings Inc, Key Employees 26
Medpace Holdings Inc, Other Locations 28
Medpace Holdings Inc, Subsidiaries 29

List of Figures
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medpace Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Medpace Holdings Inc (MEDP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anaconda Mining Inc:企業の戦略・SWOT・財務分析
    Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • BiosanaPharma BV:製薬・医療:M&Aディール及び事業提携情報
    Summary BiosanaPharma BV (Biosana) is a biotechnology company engaged in the development of monoclonal antibody biologicals (mAbs), biosimilars and biobetters. Its pipeline products include BP001: biosimilar of Omalizumab (anti-allergy); BP002: biosimilar of Denosumab (anti-osteoporosis); BOX001: or …
  • Curevac AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical-stage biopharmaceutical company that develops RNA-based medicines. The company develops, designs, and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RN …
  • Balaji Amines Ltd (BALAMINES)
    Balaji Amines Ltd (BALAMINES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Alliqua BioMedical Inc (ALQA):製薬・医療:M&Aディール及び事業提携情報
    Summary Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc, is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s products comprise ultrasound healing therapy, human biologics, antimicrobial protecti …
  • Span Diagnostics Ltd (524727)-医療機器分野:企業M&A・提携分析
    Summary Span Diagnostics Ltd (SPAN) is a medical equipment company that develops and manufactures diagnostic products for healthcare markets. The company’s products include reagents, antibiotic disc and instruments. It offers reagents such as glucose, microprotein, amylase, calcium, chloride, uric a …
  • Honeywell International Inc (HON):企業の財務・戦略的SWOT分析
    Honeywell International Inc (HON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Kbc Bank Ireland Plc:企業の戦略・SWOT・財務分析
    Kbc Bank Ireland Plc - Strategy, SWOT and Corporate Finance Report Summary Kbc Bank Ireland Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Admedes GmbH:企業の戦略的SWOT分析
    Admedes GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Dolphin Hotels plc:企業の戦略・SWOT・財務分析
    Dolphin Hotels plc - Strategy, SWOT and Corporate Finance Report Summary Dolphin Hotels plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aceto Corp (ACET):企業の財務・戦略的SWOT分析
    Aceto Corp (ACET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sun BioPharma Inc (SNBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • Vitae Pharmaceuticals Inc (VTAE)-製薬・医療分野:企業M&A・提携分析
    Summary Vitae Pharmaceuticals Inc (Vitae Pharmaceuticals) is a biopharmaceutical company that offers pharmaceutical products. The company discovers and develops and small molecule drugs for diseases with significant unmet medical needs. Its products pipeline includes VTP-34072, BI 1147560, VTP-43742 …
  • Sonoma Orthopedic Products Inc-医療機器分野:企業M&A・提携分析
    Summary Sonoma Orthopedic Products Inc (Sonoma) is a medical device company that offers orthopedic products. The company provides long bone fixation system that reduces fixation time and patient discomfort. Its product include ankle pin, collarbone pin and wrist pin. Sonoma provides treatment for wr …
  • Porton Fine Chemicals Ltd (300363):製薬・医療:M&Aディール及び事業提携情報
    Summary Porton Fine Chemicals Ltd (Porton) is a supplier of custom drug intermediates and active pharmaceutical ingredients. The company provides custom and contract chemical development, and contract manufacturing services. It provides products such as reactive reagents, chiral chromatography produ …
  • Farmer Bros. Co.:企業の戦略・SWOT・財務情報
    Farmer Bros. Co. - Strategy, SWOT and Corporate Finance Report Summary Farmer Bros. Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dai Nippon Printing Co Ltd (7912):企業の財務・戦略的SWOT分析
    Dai Nippon Printing Co Ltd (7912) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Maruti Suzuki India Ltd (MARUTI):企業の財務・戦略的SWOT分析
    Maruti Suzuki India Ltd (MARUTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Woori Bank:企業の戦略・SWOT・財務情報
    Woori Bank - Strategy, SWOT and Corporate Finance Report Summary Woori Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • MS&AD Insurance Group Holdings, Inc.:企業のM&A・事業提携・投資動向
    MS&AD Insurance Group Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MS&AD Insurance Group Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆